Wiki-CORONA

Search Results for: ERO1B

10 interactions involving ERO1B - endoplasmic reticulum oxidoreductase 1 beta found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ACTL6A actin like 6A
  • HATs acetylate histones
  • RMTs methylate histone arginines
  • UCH proteinases
  • DNA Damage Recognition in GG-NER
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
BRCA1 BRCA1 DNA repair associated
  • Meiotic synapsis
  • SUMOylation of DNA damage response and repair proteins
  • HDR through Single Strand Annealing (SSA)
  • HDR through Homologous Recombination (HRR)
  • Metalloprotease DUBs
  • Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Resolution of D-loop Structures through Holliday Junction Intermediates
  • Nonhomologous End-Joining (NHEJ)
  • Homologous DNA Pairing and Strand Exchange
  • Processing of DNA double-strand break ends
  • Presynaptic phase of homologous DNA pairing and strand exchange
  • TP53 Regulates Transcription of DNA Repair Genes
  • Regulation of TP53 Activity through Phosphorylation
  • G2/M DNA damage checkpoint
  • Transcriptional Regulation by E2F6
  • Meiotic recombination
  • Breast cancer
  • Ovarian cancer
CNRIP1 cannabinoid receptor interacting protein 1
ERP44 endoplasmic reticulum protein 44
  • Neutrophil degranulation
GNG4 G protein subunit gamma 4
  • Activation of G protein gated Potassium channels
  • Glucagon signaling in metabolic regulation
  • G-protein activation
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
  • ADP signalling through P2Y purinoceptor 12
  • G beta:gamma signalling through PI3Kgamma
  • Prostacyclin signalling through prostacyclin receptor
  • Prostacyclin signalling through prostacyclin receptor
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Ca2+ pathway
  • Ca2+ pathway
  • G alpha (q) signalling events
  • G alpha (12/13) signalling events
  • G beta:gamma signalling through PLC beta
  • G alpha (s) signalling events
  • ADP signalling through P2Y purinoceptor 1
  • ADP signalling through P2Y purinoceptor 1
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Glucagon-type ligand receptors
  • Thromboxane signalling through TP receptor
  • Vasopressin regulates renal water homeostasis via Aquaporins
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Presynaptic function of Kainate receptors
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
  • G beta:gamma signalling through BTK
  • G beta:gamma signalling through CDC42
  • Extra-nuclear estrogen signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2
  • PPARA activates gene expression
  • Synthesis of Ketone Bodies
  • HMG-CoA synthase (HMGCS) deficiency
P4HB prolyl 4-hydroxylase subunit beta
  • Collagen biosynthesis and modifying enzymes
  • Detoxification of Reactive Oxygen Species
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Hedgehog ligand biogenesis
  • VLDL assembly
  • Post-translational protein phosphorylation
  • Chylomicron assembly
  • Interleukin-12 signaling
  • Interleukin-23 signaling
  • Zinc
  • Ribostamycin
  • Copper
PARVA parvin alpha
  • Localization of the PINCH-ILK-PARVIN complex to focal adhesions
  • Cell-extracellular matrix interactions
  • Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
PYGM glycogen phosphorylase, muscle associated
  • Glycogen breakdown (glycogenolysis)
  • Glycogen breakdown (glycogenolysis)
  • Pyridoxal Phosphate
  • Beta-D-Glucopyranose Spirohydantoin
  • 3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
  • alpha-D-glucose 6-phosphate
  • 1-N-Acetyl-Beta-D-Glucosamine
  • Fluoro-Phosphite Ion
  • Beta-D-Glucose
  • 3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
  • Nojirimycine Tetrazole
  • Indirubin-5-Sulphonate
  • 2-Deoxy-Glucose-6-Phosphate
  • C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide
  • Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide
  • alpha-D-glucose-1-phosphate
  • 8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One
  • 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
  • 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole
  • N-Acetyl-N'-Beta-D-Glucopyranosyl Urea
  • 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
  • C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
  • 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
  • 5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide
  • (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
  • 8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione
  • Alvocidib
  • 1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose
  • N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide
  • 1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide
  • 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
  • 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium
  • N'-Pyridoxyl-Lysine-5'-Monophosphate
  • Heptulose-2-Phosphate
  • N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea
  • Dexfosfoserine
  • 1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide
  • Inosinic Acid
  • 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID
  • 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID
  • 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID
  • 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID
  • 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL
  • ({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID
  • (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol
  • 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID
  • (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
  • (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
  • Glycogen storage diseases (GSD), including: von Gierke disease (GSD type Ia); Pompe disease (GSD type II); Cori disease, Forbe disease (GSD type III); Andersen disease (GSD type IV); McArdle disease (GSD type V); Hers disease (GSD type VI); Tarui disease (GSD type VII); Phosphorylase kinase deficiency (GSD type IX); Fanconi-Bickel syndrome (GSD type XI); Glycogen synthase deficiency (GSD type 0)
TARBP1 TAR (HIV-1) RNA binding protein 1